AstraZeneca | AZN - Betriebsaufwand

Aktienkurs
13,512.00
Täglich Wechseln
-436.00 -3.13%
Monatlich
-11.78%
Jährlich
25.65%
Q2 Prognose
13,721.54




Betriebsaufwand Veränderung Datum
AbbVie USD 10.27B 538M 2026-03
Alcon AG USD 2.41B 123M 2025-12
Almirall EUR 517.4M 32K 2025-12
Amgen USD 4.78B 1.12B 2026-03
argenx SE USD 914.57M 137.58M 2025-12
AstraZeneca USD 8.18B 4.35B 2026-03
Autolus Therapeutics Ltd USD 96.76M 3.94M 2025-12
Bayer EUR 10.33B 126M 2025-12
Biogen USD 1.96B 69.6M 2026-03
Bristol-Myers Squibb USD 20.07B 11.77B 2026-03
Eli Lilly USD 10.02B 285M 2026-03
Fresenius EUR 5.25B 337M 2025-12
Fresenius Medical Care EUR 4.41B 27.91M 2025-12
Galapagos EUR 120.26M 7.43M 2025-12
Genmab DKK 798M 235M 2025-12
Gilead Sciences USD 4.96B 707M 2025-12
GlaxoSmithKline GBP 5.34B 1.85B 2026-03
GRIFOLS EUR 1.71B 193M 2025-12
Haleon GBP 2.13B 277.5M 2025-06
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Lonza CHF 2.9B 184M 2025-06
Merck EUR 4.78B 669M 2025-12
Merck USD 18.17B 8.01B 2026-03
Novartis USD 9.8B 61M 2025-12
Orion EUR 302.9M 64.2M 2026-03
Pfizer USD 12.91B 79.89B 2025-12
Philips EUR 4.38B 405M 2025-12
Recordati EUR 384.01M 82.67M 2025-12
Regeneron Pharmaceuticals USD 31.42B 28.44B 2026-03
Roche Holding CHF 21.01B 10.84B 2025-12
Sanofi EUR 9.31B 1.2B 2026-03
UCB EUR 2.96B 196M 2025-12